Point-ot-care decision making, adaptive systems, and outcomes optimization (and the national directives tor improved healthcare)

Point-of-Care Testing: Performance Improvement and Evidence-Based Outcomes

Volumn , Issue , 2002, Pages 193-214

  Kost, Gerald J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042355879     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. Committee on Quality of Health Care in America, Institute of Medicine. To Err Is Human: Building a Safer Health System. National Academy Press, Washington, DC, 2000.
2. Kost GJ. Preventing medical errors in point-of-care testing: Security, validation, performance, safeguards, and connectivity. Arch Pathol Lab Med 125:1307-1315, 2001.
3. Richardson WL, Berwick DM, Bisgard JC, et al. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press, Washington DC, 2001.
4. World Health Organization. Health Systems: Improving Performance. The World Health Report 2000. WHO, Geneva, Switzerland, 2000.
5. Tang Z, Louie RF, Kost GJ. Glucose meter measurements in point-of-care testing: Advantages and disadvantages in critical care. Global Health Care. World Medical Association, London, 2000, CD-ROM.
6. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. Churchill Livingstone, New York, 2000.
7. Salem M, Chemow B, Burke R, Stacey JA, Slogoff M, Sood S. Bedside diagnostic blood testing: Its accuracy, rapidity, and utility in blood conservation. JAMA 266: 382-389, 1991.
8. Steffes MW, Gillen JL, Fuhrman SA. Delivering clinical laboratory services to intensive care units. Clin Chem 42:387-391, 1996, and personal communication, 2001.
9. Kost GJ, Tran NK. Effects of POCT on time, process, decision making, treatment, and outcomes. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia: 2002, Appendix I.
10. Mohammad AA, Summers H, Burchfield JE, Petersen JR, Bissell MG, Okorodudu AO. STAT turnaround time: Satellite and point-to-point testing. Lab Med 27:684-688, 1996.
11. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: Therapeutic turnaround time and staff satisfaction. Clin Chem 44: 1597-1603, 1998.
12. Kost GJ, Hague C. The current and future status of critical care testing and patient monitoring. Pathology Patterns. Am J Clin Pathol 104(suppl 1):S2-S17, 1995.
13. Kost GJ, Hague C. In vitro, ex vivo, and in vivo biosensor systems. In: Kost GJ, ed. Handbook of Clinical Automation, Robotics, and Optimization. Wiley, New York, 1996, pp 648-753.
14. Kost GJ. The clinical systems manager: Optimizing point-of-care testing. Clin Lab Manage Rev 12:353-363, 1998.
15. Senge PM. The Fifth Discipline: The Art and Practice of the Learning Organization. Currency Doubleday, New York, 1990.
16. Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002.
17. Kost GJ. Critical limits for urgent clinician notification at US medical centers. JAMA 263:704-707, 1990.
18. Kost GJ. Critical limits for emergency clinician notification at United States children’s hospitals. Pediatrics 88:597-603, 1991.
19. Kost GJ. The significance of ionized calcium in cardiac and critical care: Availability and critical limits at US medical centers and children’s hospitals. Arch Pathol Lab Med 177:890-896, 1993.
20. Kost GJ. Using critical limits to improve patient outcome. Med Lab Observ 25:2227, 1993.
21. Kost GJ. Designing critical limit systems for knowledge optimization. Arch Pathol Lab Med 120:616-618, 1996.
22. +] to diagnosis and treatment. Acta Anesthesiol Scand 39(suppl 107):273-279, 1995.
23. Zaloga GP, Kirby RR, Bernards WC, Layon AJ. Fluid and Electrolytes. In: Civetta JM, Taylor RW. Kirby RR. eds. Critical Care. Lippincott-Raven. Philadelphia, 1997, pp 413-442.
24. Forrest ARW, Shenkin A. Dangerous pseudohyponatremia. Lancet 2:1256, 1980.
25. Frier BM, Steer CR, Baird JD, Bloomfield S. Misleading plasma electrolytes in diabetic children with severe hyperlipidemia. Arch Dis Child 55:771-775, 1980.
26. Nanji AA, Blank DW. Pseudohyponatremia and hyperviscosity. J Clin Pathol 36: 834-835, 1983.
27. Pain RW. Test and teach (41). Diagnosis: Hypertriglyceridemia with pseudohyponatremia in acute and chronic alcoholism. Pathology 15:331-334, 1983.
28. Aw TC, Keichle FL. Pseudohyponatremia. Am J Emerg Med 3:236-239, 1985.
29. Howard JM, Reed J. Pseudohyponatremia in acute hyperlipemic pancreatitis. A potential pitfall in therapy. Arch Surg 120:1053-1055, 1985.
30. Weisberg LS. Pseudohyponatremia: A reappraisal. Am J Med 86:315-318, 1989.
31. Kost GJ. Accurate and efficient diagnosis of hyperosmolar coma. Audio-Digest Intern Med Vol 38, no. 10, May 22, 1991.
32. Grateau G, Bachmeyer C, Taulera O, Sarfati G, Cremer G, Sereni D. Pseudohyponatremia and pseudohyperphosphatemia in a patient with human immunodeficiency virus infection. Nephron 46:640, 1993.
33. Vaswani SK, Sprague R. Pseudohyponatremia in multiple myeloma. South Med J 86:251-252, 1993.
34. Olivero JJ. Case in point. Pseudohyponatremia due to hyperproteinemia in multiple myeloma. Hosp Pract 29:61, 1994.
35. Sachs C, Levillain P. The real cause of discrepancy between plasma sodium results obtained by ISE and “dilution” techniques: An error in the dilution factor. AACC Electrolyte/Blood Gas Division Newsletter 9:2-4, 1994.
36. Lawn N, Wijdicks EF, Burritt MF. Intravenous immune globulin and pseudohyponatremia. NEJM 1998:339:632.
37. Ng SK. Intravenous immunoglobulin infusion causing pseudohyponatremia. Lupus 8:488-490, 1999.
38. Rosenthal R, Koelz A, Vogelbach P. Pseudohyponatremia. Schweizerische Medizinische Wochenschrift. J Suisse Med 130:161, 2000.
39. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatrémie encephalopathy in menstruant women. Ann Intern Med 117:891-897, 1992.
40. Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Peds 29:734-740, 1992.
41. Singhi S, Prasad SVSS, Chugh KS. Hyponatremia in sick children: A marker of serious illness. Indian Peds 31:19-25, 1994.
42. Ayus JC, Arieff AI. Pulmonary complications of hyponatrémie encephalopathy: Noncardiac pulmonary edema and hypercapnic respiratory failure. Chest 107:517-521, 1995.
43. Ayus CJ, Arieff AI. Brain damage and postoperative hyponatremia: The role of gender. Neurology 46:323-328, 1996.
44. Ayus JC, Arieff AI. Hyponatremia and myelinolysis. Ann Intern Med 127:163, 1997.
45. Ayus JC, Arieff AI. Postoperative hyponatremia. Ann Intern Med 126:1005-1006, 1997.
46. Fraser CL, Arieff Ai. Epidemiology, pathophysiology, and management of hyponatrémie encephalopathy. Am J Med 102:67-77, 1997.
47. Laureno R, Karp B. Myelinolysis after correction of hyponatremia. Ann Intern Med 126:57-62, 1997.
48. Arieff AI. Postoperative hyponatrémie encephalopathy following elective surgery in children. Paediatr Anesth 81:1-4, 1998.
49. Arieff AI, Ayus JC. Hyponatremia. N Engl J Med 343:886, 2000.
50. Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 124:197-203, 1996.
51. Kost GJ, Bullock J, Despotis GJ. On-site and near-patient testing in the operating room. In: Kost GJ. ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002.
52. Despotis GJ, Santoro SA, Spitznagel E, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 107:271-279, 1994.
53. Despotis GJ, Grishaber JE, Goodnough LT. The effect of an intraoperative treatment algorithm on physicians’ transfusion practice in cardiac surgery. Transfusion 34: 290-296, 1994.
54. Despotis GJ, Santoro SA, Spitznagel E, et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count: A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 80:338-351, 1994.
55. Goodnough LT, Despotis GJ, Hogue CW, Ferguson TB. On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 60:473-480, 1995.
56. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: Impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 43:1684-1696, 1997.
57. Despotis GJ, Skubas NJ, Goodnough LT. Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Sem Thorac Cardiovasc Surg 11: 84-104, 1999.
58. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94:773-781, 2001.
59. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Ninety-minute critical pathway for chest pain evaluation. Am J Cardiol 88:611-617, 2001.
60. Kost GJ, Lathrop JP. Designing diagnostic testing for patient-focused care. Med Lab Observ 25(9S): 16-26, 1993.
61. Kost GJ. National Guideline Clearinghouse. Web Site Review. Clin Chem 46:141-142, 2000.
62. Indrikovs AJ. The role of point-of-care testing in care paths. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002.
63. Sokoll LJ, Donovan PI, Udelsman R. Point-of-care parathyroid hormone testing. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002, case D.
64. Johnson LR, Doherty G, Lairmore T, et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preioperative imaging and concise parathyroidectomy. Clin Chem 47:919-925, 2001.
65. Kost GJ, Tran NK. The economics of point-of-care testing. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002, Appendix II.
66. Plsek P. Redesigning health care with insights from the science of complex adaptive systems. In: Richardson WL, Berwick DM, Bisgard JC, et al. Crossing the Quality Chasm: A New Health System for the 21 st Century. National Academy Press, Washington, DC, 2001. pp 309-322.
67. Apple FS. On-site evaluation of chest pain using biomarkers of myocardial injury. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002.
68. Kost GJ, Omand K, Kirk JD. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB and mass, and myoglobin) in the diagnosis of acute myocardial infarction. Arch Pathol Lab Med 122:245-251, 1998.
69. Maisel A. Point-of-care diagnosis and management of myocardial infarction and congestive heart failure. In: Kost GJ, ed. Principles and Practice of Point-of-Care Testing. Lippincott/Williams & Wilkins, Philadelphia, 2002.
70. Lustbader DR. Severe sepsis and shock: Guidelines for management. 30th International Educational and Scientific Symposium of the Society of Critical Care Medicine. February 2001, www.sccm.org.
71. International Sepsis Forum. Guidelines for the management of severe sepsis and septic shock. Intens Care Med 27(suppl 1):S1-S134, 2001.
72. Kost GJ, Ehrmeyer SS, Chemow B, et al. The laboratory-clinical interface: Point-of-care testing. Chest 115:1140-1154, 1999.
73. Report on Patient Safety. Agency for Healthcare Research and Quality. AHRQ, Washington, DC, 2002, www.ahcpr.gov.
74. Kost GJ. Point-of-Care Testing => The Hybrid Laboratory => Knowledge Optimization. In: Kost GJ, ed. Handbook of Clinical Automation, Robotics, and Optimization. Wiley, New York, 1996, pp 757-838.